506 related articles for article (PubMed ID: 24620731)
1. Baseline and serial liver stiffness measurement in prediction of portal hypertension progression for patients with compensated cirrhosis.
Wang JH; Chuah SK; Lu SN; Hung CH; Kuo CM; Tai WC; Chiou SS
Liver Int; 2014 Oct; 34(9):1340-8. PubMed ID: 24620731
[TBL] [Abstract][Full Text] [Related]
2. The accuracy of noninvasive methods in predicting the development of hepatocellular carcinoma and hepatic decompensation in patients with chronic hepatitis B.
Chon YE; Jung ES; Park JY; Kim DY; Ahn SH; Han KH; Chon CY; Jung KS; Kim SU
J Clin Gastroenterol; 2012 Jul; 46(6):518-25. PubMed ID: 22688146
[TBL] [Abstract][Full Text] [Related]
3. Utility of transient elastography in the non-invasive evaluation of cystic fibrosis liver disease.
Kitson MT; Kemp WW; Iser DM; Paul E; Wilson JW; Roberts SK
Liver Int; 2013 May; 33(5):698-705. PubMed ID: 23432782
[TBL] [Abstract][Full Text] [Related]
4. Liver stiffness measurement as a predictive tool of clinically significant portal hypertension in patients with compensated hepatitis C virus or alcohol-related cirrhosis.
Lemoine M; Katsahian S; Ziol M; Nahon P; Ganne-Carrie N; Kazemi F; Grando-Lemaire V; Trinchet JC; Beaugrand M
Aliment Pharmacol Ther; 2008 Nov; 28(9):1102-10. PubMed ID: 18691352
[TBL] [Abstract][Full Text] [Related]
5. The role of liver stiffness measurement in the evaluation of liver function and esophageal varices in cirrhotic patients.
Hua J; Liu GQ; Bao H; Sheng L; Guo CJ; Li H; Ma X; Shen JL
J Dig Dis; 2015 Feb; 16(2):98-103. PubMed ID: 25385497
[TBL] [Abstract][Full Text] [Related]
6. Prospective risk assessment for hepatocellular carcinoma development in patients with chronic hepatitis C by transient elastography.
Masuzaki R; Tateishi R; Yoshida H; Goto E; Sato T; Ohki T; Imamura J; Goto T; Kanai F; Kato N; Ikeda H; Shiina S; Kawabe T; Omata M
Hepatology; 2009 Jun; 49(6):1954-61. PubMed ID: 19434742
[TBL] [Abstract][Full Text] [Related]
7. Good performance of liver stiffness measurement in the prediction of postoperative hepatic decompensation in patients with cirrhosis complicated with hepatocellular carcinoma.
Procopet B; Fischer P; Horhat A; Mois E; Stefanescu H; Comsa M; Graur F; Bartos A; Lupsor-Platon M; Badea R; Grigorescu M; Tantau M; Sparchez Z; Al Hajjar N
Med Ultrason; 2018 Aug; 20(3):272-277. PubMed ID: 30167578
[TBL] [Abstract][Full Text] [Related]
8. Role of liver and spleen stiffness in predicting the recurrence of hepatocellular carcinoma after resection.
Marasco G; Colecchia A; Colli A; Ravaioli F; Casazza G; Bacchi Reggiani ML; Cucchetti A; Cescon M; Festi D
J Hepatol; 2019 Mar; 70(3):440-448. PubMed ID: 30389551
[TBL] [Abstract][Full Text] [Related]
9. Liver stiffness measurement as an alternative to fibrotic stage in risk assessment of hepatocellular carcinoma incidence for chronic hepatitis C patients.
Wang HM; Hung CH; Lu SN; Chen CH; Lee CM; Hu TH; Wang JH
Liver Int; 2013 May; 33(5):756-61. PubMed ID: 23405889
[TBL] [Abstract][Full Text] [Related]
10. Liver stiffness-based score in hepatoma risk assessment for chronic hepatitis C patients after successful antiviral therapy.
Wang JH; Yen YH; Yao CC; Hung CH; Chen CH; Hu TH; Lee CM; Lu SN
Liver Int; 2016 Dec; 36(12):1793-1799. PubMed ID: 27254286
[TBL] [Abstract][Full Text] [Related]
11. Liver stiffness-based optimization of hepatocellular carcinoma risk score in patients with chronic hepatitis B.
Wong GL; Chan HL; Wong CK; Leung C; Chan CY; Ho PP; Chung VC; Chan ZC; Tse YK; Chim AM; Lau TK; Wong VW
J Hepatol; 2014 Feb; 60(2):339-45. PubMed ID: 24128413
[TBL] [Abstract][Full Text] [Related]
12. Non-invasive prediction of liver-related events in patients with HCV-associated compensated advanced chronic liver disease after oral antivirals.
Pons M; Rodríguez-Tajes S; Esteban JI; Mariño Z; Vargas V; Lens S; Buti M; Augustin S; Forns X; Mínguez B; Genescà J
J Hepatol; 2020 Mar; 72(3):472-480. PubMed ID: 31629779
[TBL] [Abstract][Full Text] [Related]
13. Liver stiffness accurately predicts portal hypertension related complications in patients with chronic liver disease: a prospective study.
Robic MA; Procopet B; Métivier S; Péron JM; Selves J; Vinel JP; Bureau C
J Hepatol; 2011 Nov; 55(5):1017-24. PubMed ID: 21354450
[TBL] [Abstract][Full Text] [Related]
14. Liver stiffness measurement in patients with cirrhosis and hepatocellular carcinoma: a case-control study.
Nahon P; Kettaneh A; Lemoine M; Seror O; Barget N; Trinchet JC; Beaugrand M; Ganne-Carrié N
Eur J Gastroenterol Hepatol; 2009 Feb; 21(2):214-9. PubMed ID: 19212210
[TBL] [Abstract][Full Text] [Related]
15. Liver Stiffness by Transient Elastography to Detect Porto-Sinusoidal Vascular Liver Disease With Portal Hypertension.
Elkrief L; Lazareth M; Chevret S; Paradis V; Magaz M; Blaise L; Rubbia-Brandt L; Moga L; Durand F; Payancé A; Plessier A; Chaffaut C; Valla D; Malphettes M; Diaz A; Nault JC; Nahon P; Audureau E; Ratziu V; Castera L; Garcia Pagan JC; Ganne-Carrie N; Rautou PE;
Hepatology; 2021 Jul; 74(1):364-378. PubMed ID: 33345307
[TBL] [Abstract][Full Text] [Related]
16. The usefulness of non-invasive liver stiffness measurements in predicting clinically significant portal hypertension in cirrhotic patients: Korean data.
Hong WK; Kim MY; Baik SK; Shin SY; Kim JM; Kang YS; Lim YL; Kim YJ; Cho YZ; Hwang HW; Lee JH; Chae MH; Kim HA; Kang HW; Kwon SO
Clin Mol Hepatol; 2013 Dec; 19(4):370-5. PubMed ID: 24459641
[TBL] [Abstract][Full Text] [Related]
17. Impact of liver-stiffness measurement on hepatocellular carcinoma development in chronic hepatitis C patients treated with direct-acting antivirals: A systematic review and time-to-event meta-analysis.
You MW; Kim KW; Shim JJ; Pyo J
J Gastroenterol Hepatol; 2021 Mar; 36(3):601-608. PubMed ID: 32875681
[TBL] [Abstract][Full Text] [Related]
18. Liver stiffness measurement, better than APRI, Fibroindex, Fib-4, and NBI gastroscopy, predicts portal hypertension in patients with cirrhosis.
Zhang W; Wang L; Wang L; Li G; Huang A; Yin P; Yang Z; Ling C; Wang L
Cell Biochem Biophys; 2015 Mar; 71(2):865-73. PubMed ID: 25417057
[TBL] [Abstract][Full Text] [Related]
19. Liver stiffness plus platelet count can be used to exclude high-risk oesophageal varices.
Ding NS; Nguyen T; Iser DM; Hong T; Flanagan E; Wong A; Luiz L; Tan JY; Fulforth J; Holmes J; Ryan M; Bell SJ; Desmond PV; Roberts SK; Lubel J; Kemp W; Thompson AJ
Liver Int; 2016 Feb; 36(2):240-5. PubMed ID: 26212020
[TBL] [Abstract][Full Text] [Related]
20. Transient elastography to rule out esophageal varices and portal hypertensive gastropathy in HIV-infected individuals with liver cirrhosis.
Montes Ramirez ML; Pascual-Pareja JF; Sánchez-Conde M; Bernardino De la Serna JI; Zamora Vargas FX; Miralles P; Castro JM; Ramírez M; Gutierrez I; Gonzalez-García J; Berenguer J; Arribas López JR
AIDS; 2012 Sep; 26(14):1807-12. PubMed ID: 22781218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
